Skip to Content
Merck
  • Assessment of the sedative effects of buprenorphine administered with 20 microg/kg detomidine in horses.

Assessment of the sedative effects of buprenorphine administered with 20 microg/kg detomidine in horses.

The Veterinary record (2011-04-16)
E J Love, P M Taylor, J Murrell, H R Whay, A E Waterman-Pearson
ABSTRACT

The aim of this randomised, observer-blinded, crossover study was to compare the effects of four treatments, administered intravenously to six horses: saline and saline; 10 µg/kg detomidine and 7.5 µg/kg buprenorphine; 20 µg/kg detomidine and 7.5 µg/kg buprenorphine; and 20 µg/kg detomidine and 10 µg/kg buprenorphine. Sedation was subjectively assessed and recorded on a visual analogue scale. Peak sedation and duration of sedation were investigated using a univariate general linear model with post-hoc Tukey tests (P<0.05). Increasing the dose of detomidine from 10 to 20 µg/kg increased the degree of sedation when administered with the same dose of buprenorphine (7.5 µg/kg). When administered with 20 µg/kg detomidine, increasing the dose of buprenorphine from 7.5 to 10 µg/kg did not influence the degree of sedation achieved.

MATERIALS
Product Number
Brand
Product Description

Detomidine hydrochloride, European Pharmacopoeia (EP) Reference Standard